Molecular Biomarkers in Traumatic Brain Injury: Diagnostic, Prognostic, and Therapeutic Perspective
DOI:
10.29303/jbt.v25i4.10237Published:
2025-10-01Downloads
Abstract
Traumatic Brain Injury (TBI) remains a major global health problem due to its high morbidity and mortality rates. TBI can lead to cognitive and emotional impairments, and even increase the risk of neurodegenerative diseases such as Alzheimer's and Parkinson's. This review was compiled by searching literature discussing the role of molecular biomarkers in TBI, both from diagnostic and prognostic perspectives, as well as their therapeutic potential. The article search was conducted via PubMed, ScienceDirect, and Google Scholar using relevant keywords. The findings showed that with the increasing number of TBI cases, the limitations of CT scans and the Glasgow Coma Scale (GCS) in assessing subtle brain damage have spurred interest in molecular biomarkers. Biomarkers such as GFAP, S100B, tau protein, UCH-L1, and NF-L have been shown to detect biological changes not visible on routine imaging. GFAP emerges as the most promising candidate due to its high sensitivity and specificity in assessing injury severity. Thus, molecular biomarkers have the potential to improve diagnostic accuracy, predict prognosis, and support more effective rehabilitation strategies. The conclusion is that TBI is a global health problem with serious long-term impacts. Molecular biomarkers offer a great opportunity to complement conventional diagnostic methods. Although challenges remain in validation, standardization, and clinical application, further research can pave the way for the use of biomarkers as diagnostic and prognostic tools, as well as a basis for more personalized therapy in TBI patients.
Keywords:
Biomarkers, molecular, traumatic brain injury.References
Agoston, D. V., & Helmy, A. (2023). Fluid-Based Protein Biomarkers in Traumatic Brain Injury: The View from the Bedside. In International Journal of Molecular Sciences (Vol. 24, Issue 22). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/ijms242216267
Akhyar, R. B. F., Rosyidi, R. M., & Priyanto, B. (2023). TINJAUAN PUSTAKA: DIAGNOSIS DAN TATALAKSANA CEDERA OTAK TRAUMATIK. In Jurnal Ilmu Kedokteran dan Kesehatan (Vol. 10, Issue 12). http://ejurnalmalahayati.ac.id/index.php/kesehatan
Behzadi, F., Luy, D. D., Schaible, P. A., Zywiciel, J. F., Puccio, A. M., & Germanwala, A. V. (2024). A systematic review and meta-analysis of major blood protein biomarkers that predict unfavorable outcomes in severe traumatic brain injury. Clinical Neurology and Neurosurgery, 242, 108312. https://doi.org/10.1016/j.clineuro.2024.108312
Brandl, S., & Reindl, M. (2023). Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models. In International Journal of Molecular Sciences (Vol. 24, Issue 16). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/ijms241612699
Brazinova, A., Rehorcikova, V., Taylor, M. S., Buckova, V., Majdan, M., Psota, M., Peeters, W., Feigin, V., Theadom, A., Holkovic, L., & Synnot, A. (2021). Epidemiology of Traumatic Brain Injury in Europe: A Living Systematic Review. In Journal of Neurotrauma (Vol. 38, Issue 10, pp. 1411–1440). Mary Ann Liebert Inc. https://doi.org/10.1089/neu.2015.4126
Butkova, T. V., Malsagova, K. A., Nakhod, V. I., Petrovskiy, D. V., Izotov, A. A., Balakin, E. I., Yurku, K. A., Umnikov, A. S., Pustovoyt, V. I., & Kaysheva, A. L. (2024). Candidate Molecular Biomarkers of Traumatic Brain Injury: A Systematic Review. In Biomolecules (Vol. 14, Issue 10). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/biom14101283
Chamoun, R., Suki, D., Gopinath, S. P., Goodman, J. C., & Robertson, C. (2010). Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury: Clinical article. Journal of Neurosurgery, 113(3), 564–570. https://doi.org/10.3171/2009.12.JNS09689
Cho, M. J., & Jang, S. H. (2021). Relationship between post-traumatic amnesia and white matter integrity in traumatic brain injury using tract-based spatial statistics. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-86439-0
Dadas, A., Washington, J., Diaz-Arrastia, R., & Janigro, D. (2018). Biomarkers in traumatic brain injury (TBI): A review. In Neuropsychiatric Disease and Treatment (Vol. 14, pp. 2989–3000). Dove Medical Press Ltd. https://doi.org/10.2147/NDT.S125620
Diaz-Arrastia, R., Wang, K. K. W., Papa, L., Sorani, M. D., Yue, J. K., Puccio, A. M., McMahon, P. J., Inoue, T., Yuh, E. L., Lingsma, H. F., Maas, A. I. R., Valadka, A. B., Okonkwo, D. O., Manley, G. T., Casey, I. S. S., Cheong, M., Cooper, S. R., Dams-O’Connor, K., Gordon, W. A., … Vassar, M. J. (2014). Acute biomarkers of traumatic brain injury: Relationship between plasma levels of ubiquitin C-terminal hydrolase-l1 and glial fibrillary acidic protein. Journal of Neurotrauma, 31(1), 19–25. https://doi.org/10.1089/neu.2013.3040
Gao, T. L., Yuan, X. T., Yang, D., Dai, H. L., Wang, W. J., Peng, X., Shao, H. J., Jin, Z. F., & Fu, Z. J. (2012). Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury. Journal of Trauma and Acute Care Surgery, 72(3), 643–649. https://doi.org/10.1097/TA.0b013e31823c54a6
Ghaith, H. S., Nawar, A. A., Gabra, M. D., Abdelrahman, M. E., Nafady, M. H., Bahbah, E. I., Ebada, M. A., Ashraf, G. M., Negida, A., & Barreto, G. E. (2022). A Literature Review of Traumatic Brain Injury Biomarkers. In Molecular Neurobiology (Vol. 59, Issue 7, pp. 4141–4158). Springer. https://doi.org/10.1007/s12035-022-02822-6
Gutierre, M. U., Telles, J. P. M., Welling, L. C., Rabelo, N. N., Teixeira, M. J., & Figueiredo, E. G. (2021). Biomarkers for traumatic brain injury: a short review. In Neurosurgical Review (Vol. 44, Issue 4, pp. 2091–2097). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s10143-020-01421-0
Hall, E. D., Vaishnav, R. A., & Mustafa, A. G. (2010). Antioxidant Therapies for Traumatic Brain Injury.
Hossain, I., Marklund, N., Czeiter, E., Hutchinson, P., & Buki, A. (2023). Blood biomarkers for traumatic brain injury: A narrative review of current evidence. Brain & Spine, 4, 102735. https://doi.org/10.1016/j.bas.2023.102735
Johnson, N. H., Hadad, R., Taylor, R. R., Pilar, J. R., Salazar, O., Llompart-Pou, J. A., Dietrich, W. D., Keane, R. W., Pérez-Bárcena, J., & Vaccari, J. P. de R. (2022). Inflammatory Biomarkers of Traumatic Brain Injury. Pharmaceuticals, 15(6). https://doi.org/10.3390/ph15060660
Johnson, V. E., Stewart, W., & Smith, D. H. (2013). Axonal pathology in traumatic brain injury. In Experimental Neurology (Vol. 246, pp. 35–43). https://doi.org/10.1016/j.expneurol.2012.01.013
Juwita, Hidayaturrahmi, Adista, M. A., & Khairunnisa. (2024). Biomarker Prognostik pada Cedera Otak Traumatik: Manakah yang Terbaik? 5.
Krausz, A. D., Korley, F. K., & Burns, M. A. (2021). The current state of traumatic brain injury biomarker measurement methods. Biosensors, 11(9). https://doi.org/10.3390/bios11090319
Kuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016). Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clinical Chemistry and Laboratory Medicine, 54(10), 1655–1661. https://doi.org/10.1515/cclm-2015-1195
Lipsky, R. H., Witkin, J. M., Shafique, H., Smith, J. L., Cerne, R., & Marini, A. M. (2024). Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management. In Frontiers in Neuroscience (Vol. 18). Frontiers Media SA. https://doi.org/10.3389/fnins.2024.1446076
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013). BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. In Nature Reviews Neuroscience (Vol. 14, Issue 6, pp. 401–416). https://doi.org/10.1038/nrn3505
Maas, A. I. R., Menon, D. K., Manley, G. T., Abrams, M., Åkerlund, C., Andelic, N., Aries, M., Bashford, T., Bell, M. J., Bodien, Y. G., Brett, B. L., Büki, A., Chesnut, R. M., Citerio, G., Clark, D., Clasby, B., Cooper, D. J., Czeiter, E., Czosnyka, M., … Zumbo, F. (2022). Traumatic brain injury: progress and challenges in prevention, clinical care, and research. In The Lancet Neurology (Vol. 21, Issue 11, pp. 1004–1060). Elsevier Ltd. https://doi.org/10.1016/S1474-4422(22)00309-X
Magnusson, B. M., & Koskinen, L. O. D. (2024). Classification and Characterization of Traumatic Brain Injuries in the Northern Region of Sweden. Journal of Clinical Medicine, 13(1). https://doi.org/10.3390/jcm13010008
Mahley, R. W. (1988). Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology. www.sciencemag.org
Mcconeghy, K. W., Hatton, J., Hughes, L., & Cook, A. M. (2012). A Review of Neuroprotection Pharmacology and Therapies in Patients with Acute Traumatic Brain Injury.
McFadyen, C. A., Zeiler, F. A., Newcombe, V., Synnot, A., Steyerberg, E., Gruen, R. L., Rosand, J., Palotie, A., Maas, A. I. R., & Menon, D. K. (2021). Apolipoprotein E4 Polymorphism and Outcomes from Traumatic Brain Injury: A Living Systematic Review and Meta-Analysis. In Journal of Neurotrauma (Vol. 38, Issue 8, pp. 1124–1136). Mary Ann Liebert Inc. https://doi.org/10.1089/neu.2018.6052
Mena, J. H., Sanchez, A. I., Rubiano, A. M., Peitzman, A. B., Sperry, J. L., Gutierrez, M. I., & Puyana, J. C. (2011). Effect of the modified glasgow coma scale score criteria for mild traumatic brain injury on mortality prediction: Comparing classic and modified glasgow coma scale score model scores of 13. Journal of Trauma - Injury, Infection and Critical Care, 71(5), 1185–1193. https://doi.org/10.1097/TA.0b013e31823321f8
Michetti, F., D’Ambrosi, N., Toesca, A., Puglisi, M. A., Serrano, A., Marchese, E., Corvino, V., & Geloso, M. C. (2019). The S100B story: from biomarker to active factor in neural injury. In Journal of Neurochemistry (Vol. 148, Issue 2, pp. 168–187). Blackwell Publishing Ltd. https://doi.org/10.1111/jnc.14574
Mondello, S., Papa, L., Buki, A., Bullock, M. R., Czeiter, E., Tortella, F. C., Wang, K. K., & Hayes, R. L. (2011). Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: A case control study. Critical Care, 15(3). https://doi.org/10.1186/cc10286
Mondello, S., Shear, D. A., Bramlett, H. M., Dixon, C. E., Schmid, K. E., Dietrich, W. D., Wang, K. K. W., Hayes, R. L., Glushakova, O., Catania, M., Richieri, S. P., Povlishock, J. T., Tortella, F. C., & Kochanek, P. M. (2016). Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy. Journal of Neurotrauma, 33(6), 595–605. https://doi.org/10.1089/neu.2015.4132
Mondello, S., Sorinola, A., Czeiter, E., Vámos, Z., Amrein, K., Synnot, A., Donoghue, E., Sándor, J., Wang, K. K. W., Diaz-Arrastia, R., Steyerberg, E. W., Menon, D. K., Maas, A. I. R., & Buki, A. (2021). Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis. In Journal of Neurotrauma (Vol. 38, Issue 8, pp. 1086–1106). Mary Ann Liebert Inc. https://doi.org/10.1089/neu.2017.5182
Myrga, J. M., Juengst, S. B., Failla, M. D., Conley, Y. P., Arenth, P. M., Grace, A. A., & Wagner, A. K. (2016). COMT and ANKK1 Genetics Interact with Depression to Influence Behavior Following Severe TBI: An Initial Assessment. Neurorehabilitation and Neural Repair, 30(10), 920–930. https://doi.org/10.1177/1545968316648409
National Academies of Sciences, Engineering, and Medicine. (2019). Traumatic brain injury: A roadmap for accelerating progress. Washington, DC: National Academies Press. https://doi.org/10.17226/25394
Ng, S. Y., & Lee, A. Y. W. (2019). Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets. In Frontiers in Cellular Neuroscience (Vol. 13). Frontiers Media S.A. https://doi.org/10.3389/fncel.2019.00528
Osthoff, M., Katan, M., Fluri, F., Schuetz, P., Bingisser, R., Kappos, L., Steck, A. J., Engelter, S. T., Mueller, B., Christ-Crain, M., & Trendelenburg, M. (2011). Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS ONE, 6(6). https://doi.org/10.1371/journal.pone.0021338
Papa, L., Ramia, M. M., Kelly, J. M., Burks, S. S., Pawlowicz, A., & Berger, R. P. (2013). Systematic review of clinical research on biomarkers for pediatric traumatic brain injury. In Journal of Neurotrauma (Vol. 30, Issue 5, pp. 324–338). https://doi.org/10.1089/neu.2012.2545
Raghupathi, R. (2004). Cell Death Mechanisms Following Traumatic Brain Injury.
Ramzi, A., & Hunaifi, I. (2024). Diagnosis and Management of Post Traumatic Epilepsy. Jurnal Biologi Tropis, 24(4), 403–412. https://doi.org/10.29303/jbt.v24i4.7667
Semple, B. D., Kossmann, T., & Morganti-Kossmann, M. C. (2010). Role of chemokines in CNS health and pathology: A focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. In Journal of Cerebral Blood Flow and Metabolism (Vol. 30, Issue 3, pp. 459–473). https://doi.org/10.1038/jcbfm.2009.240
Shahim, P., Gren, M., Liman, V., Andreasson, U., Norgren, N., Tegner, Y., Mattsson, N., Andreasen, N., Öst, M., Zetterberg, H., Nellgård, B., & Blennow, K. (2016). Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Scientific Reports, 6. https://doi.org/10.1038/srep36791
Shahim, P., Linemann, T., Inekci, D., Karsdal, M. A., Blennow, K., Tegner, Y., Zetterberg, H., & Henriksen, K. (2016). Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players. Journal of Neurotrauma, 33(22), 1995–1999. https://doi.org/10.1089/neu.2014.3741
Shenton, M. E., Hamoda, H. M., Schneiderman, J. S., Bouix, S., Pasternak, O., Rathi, Y., Vu, M. A., Purohit, M. P., Helmer, K., Koerte, I., Lin, A. P., Westin, C. F., Kikinis, R., Kubicki, M., Stern, R. A., & Zafonte, R. (2012). A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury. In Brain Imaging and Behavior (Vol. 6, Issue 2, pp. 137–192). Springer Science and Business Media, LLC. https://doi.org/10.1007/s11682-012-9156-5
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010). Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. In Nature Reviews Neurology (Vol. 6, Issue 7, pp. 393–403). https://doi.org/10.1038/nrneurol.2010.74
Simon, D. W., McGeachy, M. J., Baylr, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017). The far-reaching scope of neuroinflammation after traumatic brain injury. In Nature Reviews Neurology (Vol. 13, Issue 3, pp. 171–191). Nature Publishing Group. https://doi.org/10.1038/nrneurol.2017.13
Slavoaca, D., Muresanu, D., Birle, C., Rosu, O. V., Chirila, I., Dobra, I., Jemna, N., Strilciuc, S., & Vos, P. (2020). Biomarkers in traumatic brain injury: new concepts. In Neurological Sciences (Vol. 41, Issue 8, pp. 2033–2044). Springer-Verlag Italia s.r.l. https://doi.org/10.1007/s10072-019-04238-y
Stępniewska, E., Kałas, M., Świderska, J., & Siemiński, M. (2024). mTBI Biological Biomarkers as Predictors of Postconcussion Syndrome—Review. In Brain Sciences (Vol. 14, Issue 5). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/brainsci14050513
Tajik, M., & Noseworthy, M. D. (2022). A review of molecular and genetic factors for determining mild traumatic brain injury severity and recovery. Brain Disorders, 8, 100058. https://doi.org/10.1016/j.dscb.2022.100058
Tenovuo, O., Diaz-Arrastia, R., Goldstein, L. E., Sharp, D. J., van der Naalt, J., & Zasler, N. D. (2021). Assessing the severity of traumatic brain injury—time for a change? In Journal of Clinical Medicine (Vol. 10, Issue 1, pp. 1–12). MDPI. https://doi.org/10.3390/jcm10010148
Thelin, E. P., Zeiler, F. A., Ercole, A., Mondello, S., Büki, A., Bellander, B. M., Helmy, A., Menon, D. K., & Nelson, D. W. (2017). Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: A systematic review. In Frontiers in Neurology (Vol. 8, Issue JUL). Frontiers Media S.A. https://doi.org/10.3389/fneur.2017.00300
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011). Apolipoprotein E in Alzheimer’s disease and other neurological disorders. In The Lancet Neurology (Vol. 10, Issue 3, pp. 241–252). https://doi.org/10.1016/S1474-4422(10)70325-2
Werner, C., & Engelhard, K. (2007). Pathophysiology of traumatic brain injury. In British Journal of Anaesthesia (Vol. 99, Issue 1, pp. 4–9). Oxford University Press. https://doi.org/10.1093/bja/aem131
Woodcock, T., & Morganti-Kossmann, M. C. (2013). The role of markers of inflammation in traumatic brain injury. Frontiers in Neurology, 4 MAR. https://doi.org/10.3389/fneur.2013.00018
Xiong, Y., Mahmood, A., & Chopp, M. (2013). Animal models of traumatic brain injury. In Nature Reviews Neuroscience (Vol. 14, Issue 2, pp. 128–142). https://doi.org/10.1038/nrn3407
Yip, P. K., Carrillo-Jimenez, A., King, P., Vilalta, A., Nomura, K., Chau, C. C., Egerton, A. M. S., Liu, Z. H., Shetty, A. J., Tremoleda, J. L., Davies, M., Deierborg, T., Priestley, J. V., Brown, G. C., Michael-Titus, A. T., Venero, J. L., & Burguillos, M. A. (2017). Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration. Scientific Reports, 7. https://doi.org/10.1038/srep41689
Yiu, G., & He, Z. (2006). Glial inhibition of CNS axon regeneration. In Nature Reviews Neuroscience (Vol. 7, Issue 8, pp. 617–627). https://doi.org/10.1038/nrn1956
Zetterberg, H., & Blennow, K. (2016). Fluid biomarkers for mild traumatic brain injury and related conditions. In Nature Reviews Neurology (Vol. 12, Issue 10, pp. 563–574). Nature Publishing Group. https://doi.org/10.1038/nrneurol.2016.127
License
Copyright (c) 2025 Febi Jian Setiasari, Shaffani Mahasuary Putri, Baiq Sagitta Puspasari, Muhammad Fadani Ilham
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
